Details for Patent: 9,271,931

✉ Email this page to a colleague

Which drugs does patent 9,271,931 protect, and when does it expire?

Patent 9,271,931 protects VYXEOS and is included in one NDA.

This patent has forty-three patent family members in thirteen countries.

Summary for Patent: 9,271,931

Title:	Compositions for delivery of drug combinations
Abstract:	Compositions which comprise delivery vehicles having stably associated therewith non-antagonistic combinations of two or more agents, such as antineoplastic agents, are useful in achieving non-antagonistic effects when combinations of drugs are administered.
Inventor(s):	Tardi; Paul (Surrey, CA), Harasym; Troy (North Vancouver, CA), Webb; Murray (North Vancouver, CA), Shew; Clifford (Vancouver, CA), Janoff; Andrew (Yardley, PA), Bally; Marcel (Bowen Island, CA)
Assignee:	CELATOR PHARMACEUTICALS, INC. (Ewing, NJ)
Application Number:	10/553,373
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,271,931
Patent Claim Types: see list of patent claims	Use; Composition; Delivery; Dosage form;

Drugs Protected by US Patent 9,271,931

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Celator Pharms	VYXEOS	cytarabine; daunorubicin	POWDER;INTRAVENOUS	209401-001	Aug 3, 2017		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,271,931

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Canada	2383259	Apr 23, 2002

PCT Information
PCT Filed	April 16, 2004	PCT Application Number:	PCT/US2004/011812
PCT Publication Date:	November 04, 2004	PCT Publication Number:	WO2004/093795

International Family Members for US Patent 9,271,931

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	345775	⤷ Sign Up
Austria	475411	⤷ Sign Up
Australia	2002331480	⤷ Sign Up
Australia	2002331481	⤷ Sign Up
Australia	2002351626	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.